Mg. Maher et al., PROGNOSTIC-SIGNIFICANCE OF COLONY-STIMULATING FACTOR-RECEPTOR EXPRESSION IN IPSILATERAL BREAST-CANCER RECURRENCE, Clinical cancer research, 4(8), 1998, pp. 1851-1856
The macrophage colony-stimulating factor receptor (CSF-1R), the produc
t of the c-fms proto-oncogene, regulates normal proliferation and diff
erentiation of macrophages and trophoblasts, Recent research found abn
ormal expression of CSF-1R in human carcinomas of the breast, endometr
ium, and ovary. Furthermore, activation of CSF-1R by its ligand has be
en shown to regulate invasiveness and anchorage-independent growth in
breast carcinoma cells. To study the significance of CSF-1R expression
in breast cancer, we designed a case-controlled immunohistochemical s
tudy. We chose 80 patients from a database of 1200 early stage I or II
breast cancer patients treated with conservative surgery and radiatio
n therapy. Expression of CSF-1R in the tumors of 40 patients who exper
ienced an ipsilateral breast tumor recurrence (IBTR) as a primary site
of relapse were compared with 40 patients who had not experienced an
IBTR, The index and control patients were matched by age, clinical sta
ge, nodal status, and follow-up. Paraffin-embedded sections were immun
ostained with antibodies directed toward CSF-1R, For the CSF-1R antibo
dy, a total of 28 index cases (70%) demonstrated strong staining, wher
eas only 16 control cases (40%) demonstrated high immunoreactivity (P
= 0.007). The CSF-1R antibody showed a positive correlation for local
relapse, but no correlation was found between CSF-1R expression and di
stant metastasis, In summary, our findings provide evidence for the po
or prognostic role of CSF-1R in IBTR.